Preferences and Stated Adherence for Antibiotic Treatment of Cystic Fibrosis Pseudomonas Infections

被引：0
|
作者：
Ateesha Farah Mohamed
F. Reed Johnson
Maria-Magdalena Balp
Frederico Calado
机构：
[1] RTI-Health Solutions,Center for Clinical and Genetic Economics
[2] Novartis Pharma AG,undefined
[3] Duke Clinical Research Institute,undefined
[4] Duke University,undefined
来源：
The Patient - Patient-Centered Outcomes Research | 2016年 / 9卷
关键词：
Cystic Fibrosis; Cystic Fibrosis Patient; Preference Weight; Cystic Fibrosis Foundation; Independence From Irrelevant Alternative;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 67
页数：8
相关论文
共 50 条
  • [31] Metabotypes of Pseudomonas aeruginosa Correlate with Antibiotic Resistance, Virulence and Clinical Outcome in Cystic Fibrosis Chronic Infections
    Moyne, Oriane
    Castelli, Florence
    Bicout, Dominique J.
    Boccard, Julien
    Camara, Boubou
    Cournoyer, Benoit
    Faudry, Eric
    Terrier, Samuel
    Hannani, Dalil
    Huot-Marchand, Sarah
    Leger, Claire
    Maurin, Max
    Ngo, Tuan-Dung
    Plazy, Caroline
    Quinn, Robert A.
    Attree, Ina
    Fenaille, Francois
    Toussaint, Bertrand
    Le Gouellec, Audrey
    METABOLITES, 2021, 11 (02) : 1 - 20
  • [32] Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients
    Martin, Lois W.
    Robson, Cynthia L.
    Watts, Annabelle M.
    Gray, Andrew R.
    Wainwright, Claire E.
    Bell, Scott C.
    Ramsay, Kay A.
    Kidd, Timothy J.
    Reid, David W.
    Brockway, Ben
    Lamont, Iain L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (11)
  • [33] The Scourge of Antibiotic-resistant Infections in Cystic Fibrosis
    Price, Erin P.
    Sarovich, Derek S.
    TRENDS IN MICROBIOLOGY, 2019, 27 (04) : 289 - 291
  • [34] IMIPENEM CILASTATIN IN THE TREATMENT OF PSEUDOMONAS PULMONARY INFECTIONS IN ADULTS WITH CYSTIC-FIBROSIS (CF)
    BOWES, G
    OHEHIR, R
    FRANKLIN, C
    SPICER, J
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 : 172 - 172
  • [35] Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies
    Hassett, Daniel J.
    Korfhagen, Thomas R.
    Irvin, Randall T.
    Schurr, Michael J.
    Sauer, Karin
    Lau, Gee W.
    Sutton, Mark D.
    Yu, Hongwei
    Hoiby, Niels
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (02) : 117 - 130
  • [36] Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
    Canton, Rafael
    Maiz, Luis
    Escribano, Amparo
    Olveira, Casilda
    Oliver, Antonio
    Asensio, Oscar
    Gartner, Silvia
    Roma, Eva
    Quintana-Gallego, Esther
    Salcedo, Antonio
    Giron, Rosa
    Isabel Barrio, Maria
    Dolores Pastor, Maria
    Prados, Concepcion
    Teresa Martinez-Martinez, Maria
    Barberan, Jose
    Jose Caston, Juan
    Martinez-Martinez, Luis
    Luis Poveda, Jose
    Vazquez, Carlos
    de Gracia, Javier
    Sole, Amparo
    ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (03): : 140 - 150
  • [37] GENTAMICIN AND TOBRAMYCIN COMPARED IN THE TREATMENT OF MUCOID PSEUDOMONAS LUNG INFECTIONS IN CYSTIC-FIBROSIS
    MARTIN, AJ
    SMALLEY, CA
    GEORGE, RH
    HEALING, DE
    ANDERSON, CM
    ARCHIVES OF DISEASE IN CHILDHOOD, 1980, 55 (08) : 604 - 607
  • [38] TOBRAMYCIN IN TREATMENT OF INFECTIONS DUE TO PSEUDOMONAS-AERUGINOSA IN PATIENTS WITH CYSTIC-FIBROSIS
    CROZIER, DN
    KHAN, SR
    JOURNAL OF INFECTIOUS DISEASES, 1976, 134 : S187 - S190
  • [39] Treatment of staphylococcal infections in cystic fibrosis
    Sermet-Gaudelus, I
    REVUE DES MALADIES RESPIRATOIRES, 2003, 20 (02) : S91 - S99
  • [40] Fungal infections and treatment in cystic fibrosis
    Middleton, Peter G.
    Chen, Sharon C-A.
    Meyer, Wieland
    CURRENT OPINION IN PULMONARY MEDICINE, 2013, 19 (06) : 670 - 675
12345